These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11456479)

  • 1. Participation of critical residues from the extreme C-terminal end of the human androgen receptor in the ligand binding function.
    Tahiri B; Auzou G; Nicolas JC; Sultan C; Lupo B
    Biochemistry; 2001 Jul; 40(29):8431-7. PubMed ID: 11456479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
    Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
    Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
    Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
    Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens.
    Terouanne B; Nirdé P; Rabenoelina F; Bourguet W; Sultan C; Auzou G
    Mol Pharmacol; 2003 Apr; 63(4):791-8. PubMed ID: 12644579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
    Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action.
    Kuil CW; Berrevoets CA; Mulder E
    J Biol Chem; 1995 Nov; 270(46):27569-76. PubMed ID: 7499218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study.
    Nirdé P; Térouanne B; Gallais N; Sultan C; Auzou G
    Mol Pharmacol; 2001 May; 59(5):1307-13. PubMed ID: 11306716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34).
    Jüppner H; Schipani E; Bringhurst FR; McClure I; Keutmann HT; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV; Gardella TJ
    Endocrinology; 1994 Feb; 134(2):879-84. PubMed ID: 8299582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor.
    Shimizu M; Shimizu N; Tsang JC; Petroni BD; Khatri A; Potts JT; Gardella TJ
    Biochemistry; 2002 Nov; 41(44):13224-33. PubMed ID: 12403624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
    Govindan MV
    Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.
    Matias PM; Donner P; Coelho R; Thomaz M; Peixoto C; Macedo S; Otto N; Joschko S; Scholz P; Wegg A; Bäsler S; Schäfer M; Egner U; Carrondo MA
    J Biol Chem; 2000 Aug; 275(34):26164-71. PubMed ID: 10840043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.
    Hemmerich S; Paavola C; Bloom A; Bhakta S; Freedman R; Grunberger D; Krstenansky J; Lee S; McCarley D; Mulkins M; Wong B; Pease J; Mizoue L; Mirzadegan T; Polsky I; Thompson K; Handel TM; Jarnagin K
    Biochemistry; 1999 Oct; 38(40):13013-25. PubMed ID: 10529171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
    Shaffer PL; McDonnell DP; Gewirth DT
    Biochemistry; 2005 Feb; 44(7):2678-85. PubMed ID: 15709781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.